📰 Enavate Sciences News
Page 2 - Enavate Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Enavate Sciences. Real-time updates on events, politics, business and more.
June 29, 2023
Shares of biopharmaceutical company Immunome, Inc. (IMNM) are rising more than 36% Thursday morning after announcing merger with Morphimmune, a private biotechnology company in an all-stock transaction.
June 29, 2023
Immunome Inc (NASDAQ: IMNM) and Morphimmune have announced a merger agreement in 
June 29, 2023
Shares of biopharmaceutical company Immunome, Inc. (IMNM) are rising more than 36% Thursday morning after announcing merger with Morphimmune, a private biotechnology company in an all-stock transaction.
June 9, 2023
One of the most powerful fundraising tools a founder has is their pitch deck. But there are a few common mistakes that could ruin the whole thing.
February 2, 2023
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
February 1, 2023
/PRNewswire/ -- Patient Square Capital ("Patient Square"), a leading health care investment firm, announced today that it closed its inaugural fund with...
November 14, 2022
Insilico Medicine signed a six-drug research collaboration with Sanofi. Wuhan Neurophth announced a $140 mn agreement to use Cyagen’s AI platform to discover novel AAV vectors.
November 10, 2022
US-based immune therapy developer Zenas has significant operations in China.
November 10, 2022
MENLO PARK, Calif., Nov. 10, 2022 /PRNewswire/ -- Enavate Sciences, a portfolio company of Patient Square Capital, is pleased to announce that H. ...